Lymphomatoid Papulosis
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Lymphomatoid Papulosis

What is the definition of Lymphomatoid Papulosis?
Lymphomatoid papulosis (LyP) is a non-contagious, chronic skin condition characterized by the eruption of recurring, self-healing bumps (lesions) on the skin. The lesions typically begin small and then become larger, and they may bleed or ulcerate before becoming scaly and crusty. They often develop a red-brown color. Symptoms associated with lesions may include itching and/or pain, which may be debilitating. The frequency of eruptions varies over time and from person to person. Lesions may be very persistent, or they may go away for long periods of time before coming back. They may occur anywhere on the body, but they typically develop on the trunk, arms, and legs, and may develop on the hands, face, and genitalia. They generally go away on their own over a period of weeks to months (usually between 3 and 8 weeks), with or without scarring. LyP is not contagious. The cause of LyP is not known, but there is no evidence that it is hereditary. Stress is often reported to trigger eruptions of lesions. A diagnosis of LyP requires evaluating the symptoms and having a skin biopsy for various types of laboratory tests. While LyP usually is not classified as a cancer (although there has been some debate), it has characteristics of lymphoma under the microscope, and people with LyP have a life-long increased risk of developing lymphoma such as mycosis fungoides, PC-ALCL, or Hodgkin lymphoma. In 5 to 20 percent of people with LyP, the condition is either preceded by lymphoma, associated with lymphoma, or followed by lymphoma. When LyP is diagnosed it is important to rule out these cancers, and for this reason, various blood tests or imaging studies may also be recommended.
What are the alternative names for Lymphomatoid Papulosis?
  • Lymphomatoid papulosis
  • LyP
Who are the top Lymphomatoid Papulosis Local Doctors?
Elite in Lymphomatoid Papulosis
Dermatology
Elite in Lymphomatoid Papulosis
Dermatology
676 N St Clair St Ste 1600, Arkes Pavilion, 
Chicago, IL 
Experience:
43+ years
Languages Spoken:
English
Offers Telehealth

Joan Guitart is a Dermatologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 43 years. Dr. Guitart is rated as an Elite provider by MediFind in the treatment of Lymphomatoid Papulosis. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Lymphomatoid Papulosis. Dr. Guitart is board certified in American Board Of Dermatology - Dermatology (Certified).

Elite in Lymphomatoid Papulosis
Dermatology
Elite in Lymphomatoid Papulosis
Dermatology

UT MD Anderson Cancer Center

210 Ashville Ave # 408, 
Cary, NC 
Languages Spoken:
English
Offers Telehealth

Auris Huen is a Dermatologist practicing medicine in Cary, North Carolina. Dr. Huen is rated as an Elite provider by MediFind in the treatment of Lymphomatoid Papulosis. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Mycosis Fungoides, T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Lymphomatoid Papulosis, and Thymectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Lymphomatoid Papulosis
Dermatology | Hematology | Oncology
Elite in Lymphomatoid Papulosis
Dermatology | Hematology | Oncology
161 Fort Washington Ave # C, 
New York, NY 
Languages Spoken:
English
Offers Telehealth

Larisa Geskin is a Hematologist and a Dermatologist practicing medicine in New York, New York. Dr. Geskin is rated as an Elite provider by MediFind in the treatment of Lymphomatoid Papulosis. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Sezary Syndrome.

What are the latest Lymphomatoid Papulosis Clinical Trials?
Optimizing Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome, and Lymphomatoid Papulosis

Summary: The purpose of this study is to test any good and bad effects of the study drug called brentuximab vedotin at a lower dose than is FDA-approved.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis

Summary: To follow up with all our participants with juvenile-onset mycosis fungoides, check on their status, and ask them or their parents about long term outcomes associated with their condition.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center